{"version":"1.0","provider_name":"FYB Financial Yearbook","provider_url":"https:\/\/www.fyb.de\/en\/","author_name":"Tatjana Anderer","author_url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/","title":"Wellington Partners: new \u20ac210 million life science fund - FYB Financial Yearbook","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"sTXPuJodFP\"><a href=\"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/\">Wellington Partners: new \u20ac210 million life science fund<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/embed\/#?secret=sTXPuJodFP\" width=\"600\" height=\"338\" title=\"&#8220;Wellington Partners: new \u20ac210 million life science fund&#8221; &#8212; FYB Financial Yearbook\" data-secret=\"sTXPuJodFP\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/09\/a-sonyapauls.jpg","thumbnail_width":420,"thumbnail_height":347,"description":"Munich \u2014 Inter\u00adna\u00adtio\u00adnal law firm Clif\u00adford Chance has advi\u00adsed Welling\u00adton Part\u00adners on its successful fund\u00adrai\u00adsing for its fifth fund, Welling\u00adton Part\u00adners Life Science Fund V (WPLS\u2011V). The fund closed at \u20ac210 million, making it Welling\u00adton Part\u00adners\u2019 largest life science fund to&nbsp;date. Welling\u00adton Part\u00adners is a leading Euro\u00adpean venture capi\u00adtal firm inves\u00adt\u00ading in early and growth [&hellip;]"}